1、In this paper, these methods for the preparation of diltiazem intermediate were reviewed.
對地爾硫卓手性中間體的制備方法進(jìn)行了綜述。

2、Conclusion Betaloc in combination with diltiazem is superior to propafenone in treating paf.
結(jié)論倍他樂克與鹽酸地爾硫聯(lián)合治療陣發(fā)性房顫療效優(yōu)于普羅帕酮。

3、Objective: To observe the efficacy of diltiazem in treating coronary myocardial bridge patients.
目的觀察鈣通道拮抗劑地爾硫卓治療冠狀動脈心肌橋的療效。

4、CONCLUSIONS: Diltiazem is a strong antioxidant.
結(jié)論：地爾硫是一良好的抗氧化劑。

5、He had stopped diltiazem on his own accord.
他自行停用地爾硫卓治療。

6、He was also receiving diltiazem for cardiac arrhythmia.
他還接受了地爾硫卓治療心律不齊。

7、There was no diversity between metoprolol group and diltiazem group.
而美托洛爾組和地爾硫卓組之間無顯著性差異。

8、Objective To observe the influence of intravenous diltiazem on heart fuction.
目的評價靜注地爾硫?qū)π?a href="/zaoju/117201.htm">功能的影響，了解其臨床安全性。

9、CI increased after the bolus injection of Diltiazem or Nicardipine.
靜注地爾硫卓、尼卡地平后ci增加。